Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)

PHASE4CompletedINTERVENTIONAL

Enrollment

324

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

December 31, 2008

Conditions

Renal Insufficiency, ChronicAngioplasty, Transluminal, Percutaneous CoronaryCoronary Arteriosclerosis

Interventions

DRUG

Iodixanol 320

Iodixanol 320 is used as contrast media while coronary intervention.

DRUG

Iomeprol 350

Iomeprol 350 is used as contrast media while coronary intervention.

Trial Locations (2)

Deutsches Herzzentrum Muenchen, Munich

1. Medizinische Klinik, Klinikum rechts der Isar, München

All Listed Sponsors

lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00390585 - Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST) | Biotech Hunter | Biotech Hunter